The News Review:

- arGentis selects Target Health as Clinical Research rganization
- Influence of a Performance-Improvement Initiative on Quality of Care…
- American Cancer Society Names New Chief Medical fficer
- Ice fuelling HIV epidemic
- Pegylated Interferon Alfa-2a and Ribavirin Effective in HIV-Positive…
- Health survey to reach out to cell phone-only users

arGentis selects Target Health as Clinical Research rganization
Genetic Engineering News – Genetic Engineering News (press release) – Jul 23, 2007
The company plans to submit an Investigational New Drug application tothe FDA on both products in the fourth quarter of 2007. Target Healthwill assist in this filing and provide all regulatory and qualitydeliverables throughout the clinical trial process. About arGentis arGentis Pharmaceuticals LLC is a specialty pharmaceuticalcompany located in Memphis TN. The company seeks to in-licensetherapies for chronic diseases with demonstrated proof of concept forfurther development and commercialization. About Target Health Target Health Inc. is a New York City based full service e*CRwith staff dedicated to all aspects of Regulatory Affairs ClinicalResearch Biostatistics Data Management Internet-Based ClinicalTrials-EDC (Target e*CRF(R) Target Document(R)) SoftwareDevelopment Strategic Planning and Drug and Device Development.

Influence of a Performance-Improvement Initiative on Quality of Care…
Archives of Internal Medicine – Jul 23, 2007
Kaufman Center for Heart Failure (Dr Albert) and Department of Cardiovascular Medicine Heart Failure Section (Dr Young) Cleveland Clinic Foundation Cleveland hio; Department of Clinical Research Campbell University School of Pharmacy Research Triangle Park North Carolina (Dr Gattis Stough); and Duke Clinical Research Institute Durham (Mss Pieper and Sun). Dr Yancy is now with Baylor Heart and Vascular Institute Baylor University Medical Center Dallas. Group Information: A list of the PTIMIZE-HF hospitals and investigators was published in JAMA… Kaufman Center for Heart Failure (Dr Albert) and Department of Cardiovascular Medicine Heart Failure Section (Dr Young) Cleveland Clinic Foundation Cleveland hio; Department of Clinical Research Campbell University School of Pharmacy Research Triangle Park North Carolina (Dr Gattis Stough); and Duke Clinical Research Institute Durham (Mss Pieper and Sun). Dr Yancy is now with Baylor Heart and Vascular Institute Baylor University Medical Center Dallas. Group Information: A list of the PTIMIZE-HF hospitals and investigators was published in JAMA. THIS ARTICLE HAS BEEN CITED BY THER ARTICLES.

American Cancer Society Names New Chief Medical fficer
ACS News Center – Jul 23, 2007
Brawley served in a variety of capacities at the National Cancer Institute (NCI) with his most recent NCI position as that of director of the ffice of Special Populations Research. He is a renowned leader in the field of health disparities research. He led the National Cancer Institute Prostate Cancer Prevention Trial and also focuses his clinical research on breast cancer. Brawley is a member of the American College of Physicians the National Medical Association the American Society of Clinical ncology and the American Association for Clinical Research. He has received numerous awards throughout his career including in 2006 the U.

Ice fuelling HIV epidemic
Sydney Morning Herald – Jul 24, 2007
The research confirmed that gay sex and club drugs were adangerous combination that has the potential spread HIV “likewildfire” he said. “Gay men were already at risk and now they’re becoming even morevulnerable Dr Hurt said. Professor Cooper co-convener of the conference and director ofthe National Centre for HIV Epidemiology and Clinical Researchsaid the trend was alarming. “The effect of methamphetamine on behaviour is disastrous forthe gay population” he said. “And I fear that young straight Australians experimenting arealso more at risk. ” – AAPBellinda Kontominas reports: The AIDS Council of NSW saidDr Cooper’s findings confirmed those of Australian researchersthat the relationship between AIDS and crystal methamphetamine wascomplex. “It involves the party and sex club scenes esoteric sexualpractices meeting partners over the internet poly drug use theuse of drugs to prolong sex and importantly changing perceptionsof risk” said chief executive Stevie Clayton.

Pegylated Interferon Alfa-2a and Ribavirin Effective in HIV-Positive…
DG News – Jul 23, 2007
HIV-positive patients with acute hepatitis C are less likely to clear HCV spontaneously. nce chronic HCV is established these individuals have poorer treatment outcomes and higher risk of liver disease progression compared with individuals who are only infected with HCV. These patients were HCV antibody positive within 6 months of being recruited and had either a negative HCV antibody test with 2 years of being tested positive or an episode of hepatitis. Baseline risk factors for acquiring HCV included known HCV-positive status of partner for six patients unknown partner status for five patients and injecting drug use in seven patients.

Health survey to reach out to cell phone-only users
San Francisco Chronicle – Jul 23, 2007
Some wonder whether adding cell phones to phone surveys will be successful. Jon Foley 25 has lived without a landline for three years. A clinical research coordinator he typifies the younger cell phone-only demographic that poll takers are trying to reach. “Just answering the phone I think will be the biggest problem” he said. Foley said he rarely answers numbers he doesn’t recognize because “to be quite honest most of those calls end up being garbage. ___Information from: Los Angeles Times.